Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics.

MLA

Jiang, Yue, et al. “Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics.” Journal of Proteome Research, vol. 23, no. 7, July 2024, pp. 2343–54. EBSCOhost, https://doi.org/10.1021/acs.jproteome.3c00890.

APA

Jiang, Y., Ren, X., Zhao, J., Liu, G., Liu, F., Guo, X., Hao, M., Liu, H., Liu, K., & Huang, H. (2024). Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics. Journal of Proteome Research, 23(7), 2343–2354. https://doi.org/10.1021/acs.jproteome.3c00890

Chicago

Jiang, Yue, Xuelian Ren, Jing Zhao, Guobin Liu, Fangfang Liu, Xinlong Guo, Ming Hao, Hong Liu, Kun Liu, and He Huang. 2024. “Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics.” Journal of Proteome Research 23 (7): 2343–54. doi:10.1021/acs.jproteome.3c00890.